{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:22:12Z","timestamp":1791256932093,"version":"4.1.0"},"reference-count":66,"publisher":"Walter de Gruyter GmbH","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,1,18]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Matrix metalloproteinases (MMPs), also called matrixins, are proteinases that participate in extracellular matrix remodelling and degradation. Under normal physiological conditions, the activities of MMPs are precisely regulated at the level of transcription, of activation of the pro-MMP precursor zymogens and of inhibition by endogenous inhibitors (tissue inhibitors of metalloproteinases; TIMPs). Alteration in the regulation of MMP activity is implicated in diseases such as cancer, fibrosis, arthritis and atherosclerosis. The pathological effects of MMPs and TIMPs in cardiovascular diseases involve vascular remodelling, atherosclerotic plaque instability and left ventricular remodelling after myocardial infarction. Since excessive tissue remodelling and increased matrix metalloproteinase activity have been demonstrated during atherosclerotic lesion progression (including plaque disruption), MMPs represent a potential target for therapeutic intervention aimed at modification of vascular pathology by restoring the physiological balance between MMPs and TIMPs. This review describes the members of the MMP and TIMP families and discusses the structure, function and regulation of MMP activity; finally, pharmacological approaches to MMP inhibition are highlighted.<\/jats:p>","DOI":"10.1515\/cclm.2004.024","type":"journal-article","created":{"date-parts":[[2004,8,25]],"date-time":"2004-08-25T14:34:45Z","timestamp":1093444485000},"source":"Crossref","is-referenced-by-count":117,"title":["Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives"],"prefix":"10.1515","volume":"42","author":[{"given":"Jean-Louis","family":"Beaudeux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Giral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bruckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Jos\u00e9","family":"Foglietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. John","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","reference":[{"key":"ref31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1749-6632.2000.tb06298.x","article-title":"Erik - son Genetic diversity in the matrix metallopro - teinase family : effects on function and disease progression","volume":"10","author":"Henney","year":"2000","journal-title":"Ann Acad Sci"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0741-5214(96)70279-3","article-title":"Doxycycline inhibition of aneurysmal degeneration in an elastase - induced rat model of abdominal aortic aneurysm : preservation of aortic elas - tin associated with suppressed production of kD gela - tinase","volume":"65","author":"Petrinec","year":"1996","journal-title":"J Vasc Surg"},{"key":"ref591","first-page":"1089","article-title":"Far - well SM Doxycycline modulates smooth muscle cell growth , migration , and matrix remodelling after arterial injury","volume":"66","author":"Bendeck","year":"2003","journal-title":"Am J Pathol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0021-9258(19)85069-X","article-title":"Vas - salli JD Characterization of the cellular binding site for the urokinase - type plasminogen activator","volume":"12","author":"Estreicher","year":"1989","journal-title":"J Biol Chem"},{"key":"ref281","first-page":"1901","article-title":"Mat - sumoto AH Genetic backgrounds but not sizes of atherosclerotic lesions determine medial destruction in the aortic root of apolipoprotein E - deficient mice Arter - ioscler Thromb Vasc","volume":"35","author":"Shi","year":"2003","journal-title":"Biol"},{"key":"ref621","first-page":"2864","article-title":"MMP inhibition and the development of cere - brovascular atherosclerosis : the road ahead","volume":"69","author":"Napoli","year":"2002","journal-title":"Stroke"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/hq0901.097004","article-title":"Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin - MMP - gene inactivation","volume":"31","author":"Silence","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s000110050743","article-title":"Selective matrix metalloproteinase ( MMP ) inhibition in rheuma - toid arthritis - targetting gelatinase A activation","volume":"50","author":"Jackson","year":"2001","journal-title":"Inflamm Res"},{"key":"ref471","first-page":"201","article-title":"Matrix metalloproteinase inhibition after myocardial infarction : a new approach to prevent heart failure Circ","volume":"54","author":"Creemers","year":"2001","journal-title":"Res"},{"key":"ref481","first-page":"993","article-title":"Therapeutic potential of matrix metallopro - teinase inhibitors in atherosclerosis Expert Opin Inves - tig","volume":"55","author":"George","year":"2000","journal-title":"Drugs"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1161\/01.ATV.19.11.2640","article-title":"Oxidized LDL stimulates matrix metalloproteinase - expression in human vascular endothelial cells","volume":"27","author":"Huang","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/01.RES.0000041036.86977.14","article-title":"Targeted disruption of the matrix metalloproteinase - gene impairs smooth muscle cell migration and geometrical arterial remodelling a","volume":"32","author":"Galis","year":"2002","journal-title":"Circ Res"},{"key":"ref531","first-page":"2","article-title":"Local gene transfer of tissue inhibitor of metalloproteinase - influ - ences vein graft remodeling in a mouse model Arte - rioscler Thromb Vasc","volume":"60","author":"Hu","year":"2001","journal-title":"Biol"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1172\/JCI9626","article-title":"ApoE knockout mice expressing human matrix metalloproteinase - in macrophages have less advanced atherosclerosis","volume":"30","author":"Lemaitre","year":"2001","journal-title":"J Clin Invest"},{"key":"ref561","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1749-6632.1999.tb07723.x","article-title":"MMP inhibition reduces intimal hyperpla - sia in a human vein graft stenosis model","volume":"63","author":"Loftus","year":"1999","journal-title":"Ann NY Acad Sci"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/res.90.3.251","article-title":"Matrix metalloproteinases in vascu - lar remodeling and atherogenesis : the good , the bad , and the ugly","volume":"36","author":"Galis","year":"2002","journal-title":"Circ Res"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1172\/JCI117619","article-title":"Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human ath - erosclerotic plaques","volume":"22","author":"Galis","year":"1994","journal-title":"J Clin Invest"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0735-1097(02)01909-5","article-title":"Hel - Polymorphisms in the promoter regions of MMP - MMP - MMP - and MMP - genes as determinants of aneurysmal coronary artery disease","volume":"43","author":"Lamblin","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"ref351","first-page":"2657","article-title":"De Maat Functional polymorphism in the regula - tory region of gelatinase B gene in relation to severity of coronary","volume":"42","author":"Zhang","year":"1999","journal-title":"Circulation"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0008-6363(03)00516-9","article-title":"Matrix metallopro - teinases A review of their structure and role in acute coronary syndrome","volume":"18","author":"Jones","year":"2003","journal-title":"Cardiovasc Res"},{"key":"ref641","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/01.CIR.99.2.216","article-title":"Reduction of stroke incidence after myocardial infarction with pravastatin : the Cholesterol and Recurrent Events ( CARE ) Study The CARE Investi - gators","volume":"71","author":"Plehn","year":"1999","journal-title":"Circulation"},{"key":"ref261","first-page":"1","article-title":"Increasedmedial degradation with pseudo - aneurysm for - mation in apolipoprotein E - knockout mice deficient in tissue inhibitor of metalloproteinases -","volume":"33","author":"Lemaitre","year":"2003","journal-title":"Circulation"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1050-1738(01)00160-8","article-title":"D Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction","volume":"53","author":"Armiento","year":"2002","journal-title":"Trends Cardiovasc Med"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/01.CIR.99.3.420","article-title":"Interleukin - mediates downregulation of tis - sue inhibitor of metalloproteinase - expression in cho - lesterol - loaded human macrophages : relevance to stability of atherosclerotic plaque","volume":"25","author":"Moreau","year":"1999","journal-title":"Circulation"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1023047431869","article-title":"Matrix metalloproteinase inhibitors : the beginning of phase I or the termination of phase III clinical trials","volume":"51","author":"Pavlaki","year":"2003","journal-title":"Cancer Metastasis Rev"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s11906-003-0054-5","article-title":"Metalloproteinases and plasmino - gen activators in vessel remodelling","volume":"17","author":"Bobik","year":"2003","journal-title":"Curr Hypertens Rep"},{"key":"ref411","first-page":"131","article-title":"Rous - Circulating levels of matrix Beaudeux et al : Matrix metalloproteinases and atherosclerosis : therapeutic approaches metalloproteinases in heart transplant recipients Trans - plant","volume":"48","author":"Dorent","year":"2000","journal-title":"Proc"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/01.CIR.101.3.296","article-title":"Inhibition of late vein graft neointima formation in Beaudeux : Matrix metalloproteinases and atherosclerosis : therapeutic approaches human and porcine models by adenovirus - mediated overexpression of tissue inhibitor metalloproteinase -","volume":"15","author":"George","year":"2000","journal-title":"Circulation"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0021-9150(03)00149-7","article-title":"Serum matrix metalloproteinase - and tissue inhibitor of metalloproteinases - as potential markers of carotid atherosclerosis in infraclinical hyper - lipidemia","volume":"49","author":"Beaudeux","year":"2003","journal-title":"Atherosclerosis"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/153857440203600102","article-title":"Matrix metalloproteinase expressions in arteri - osclerotic aneurysmal disease","volume":"23","author":"Saito","year":"2002","journal-title":"Vasc Endovasc Surg"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1172\/JCI116491","article-title":"Hypercholesterole - mia increases endothelial superoxide anion production","volume":"13","author":"Ohara","year":"1993","journal-title":"J Clin Invest"},{"key":"ref541","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0741-5214(99)70354-X","article-title":"The matrix metalloproteinase inhibitor BB - limits expansion of experimental abdom - inal aortic aneurysms","volume":"61","author":"Bigatel","year":"1999","journal-title":"J Vasc Surg"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.RES.0000016501.56641.83","article-title":"Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with activation of the tissue inhibitor of matrix metalloprotei - nase - TIMP - ) gene","volume":"34","author":"Silence","year":"2002","journal-title":"Circ Res"},{"key":"ref681","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1055\/s-0037-1614087","article-title":"Cerivastatin , an inhibitor of HMG - CoA reductase , inhibits urokinase \/ urokinase - receptor expres - sion and MMP - secretion by peripheral blood mono - cytes : a possible protective mechanism against atherothrombosis","volume":"75","author":"Ganne","year":"2000","journal-title":"Thromb Haemost"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1023\/A:1025526424637","article-title":"Clin - ical implications of matrix metalloproteinases","volume":"52","author":"Mandal","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"ref701","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0167-5273(02)00368-6","article-title":"et al Effects of statin on plaque stability and thrombogen - icity in hypercholesterolemic patients with coronary artery disease","volume":"77","author":"Son","year":"2003","journal-title":"Int J Cardiol"},{"key":"ref511","article-title":"Engineering of tissue inhibitor of metalloproteinases mutants as potential therapeutics","volume":"58","author":"Nagase","year":"2002","journal-title":"Arthritis Res"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/01.CIR.0000058700.41738.12","article-title":"Plasma concentrations and genetic variation of matrix metalloproteinase and prognosis of patients with cardiovascular disease","volume":"41","author":"Blankenberg","year":"2003","journal-title":"Circulation"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1096\/fasebj.9.10.7615167","article-title":"Microscopic localization of active proteases by in situ zymography : detection of matrix metalloproteinase activity in vascular tissue","volume":"21","author":"Galis","year":"1995","journal-title":"FASEB J"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1242\/jcs.107.9.2373","article-title":"Cell growth - promoting activity of tissue inhibitor of metalloproteinases - TIMP -","volume":"14","author":"Hayakawa","year":"1994","journal-title":"J Cell Sci"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1051\/ject\/2001334218","article-title":"Evidence of increased matrix metalloprotei - nase - concentration in patients following cardiopul - monary bypass J Corpor","volume":"45","author":"Steinberg","year":"2001","journal-title":"Extra Technol"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1161\/01.ATV.20.12.2657","article-title":"Stromelysin - and inter - leukin - gene promoter polymorphisms are determi - nants of asymptomatic carotid artery atherosclerosis","volume":"40","author":"Rauramaa","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/hrt.73.3.209","article-title":"Preliminary report : genetic variation in the human stro - melysin promoter is associated with progression of cor - onary atherosclerosis","volume":"37","author":"Ye","year":"1995","journal-title":"Br Heart J"},{"key":"ref661","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/01.CIR.104.3.249","article-title":"Ches - Effects of lipid - lowering by simvastatin on human atherosclerotic lesions : a longitudinal study by high - resolution , non - invasive magnetic resonance imag - ing","volume":"73","author":"Corti","year":"2001","journal-title":"Circulation"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0741-5214(99)70216-8","article-title":"Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox isoform of cyclooxygenase","volume":"56","author":"Miralles","year":"1999","journal-title":"J Vasc Surg"},{"key":"ref691","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5551\/jat.10.109","article-title":"Naka - Plaque - stabilizing effect of pivastatin in Watanabe heritable hyperlipidemic WHHL ) rabbits","volume":"76","author":"Suzuki","year":"2003","journal-title":"J Atheroscler Thromb"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1210\/jcem.87.4.8412","article-title":"Pleiotropic effects of statins : lipid reduction and beyond","volume":"70","author":"McFarlane","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"ref671","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1042\/bst0300120","article-title":"Statins for the prevention of vein graft stenosis : a role for inhibition of matrix metallopro - teinase -","volume":"74","author":"Porter","year":"2002","journal-title":"Biochem Soc Trans"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1172\/JCI119076","article-title":"Reactive oxygen species produced by macro - phage - derived foam cells regulate the activity of vascu - lar matrix metalloproteinases in vitro Implications for atherosclerotic plaque stability","volume":"26","author":"Rajagopalan","year":"1996","journal-title":"J Clin Invest"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0735-1097(98)00250-2","article-title":"et al Peripheral blood levels of matrix metalloproteinas - es - and - are elevated in patients with acute coronary syndromes","volume":"46","author":"Kai","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"8154","DOI":"10.1073\/pnas.88.18.8154","article-title":"Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybri - dation","volume":"20","author":"Henney","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0195-668X(03)00385-3","article-title":"Variation in the matrix metal - loproteinase - gene and risk of coronary heart disease","volume":"44","author":"Ye","year":"2003","journal-title":"Eur Heart J"},{"key":"ref401","first-page":"380","article-title":"Circulating matrix metalloproteinases and their inhibitors in premature coronary atheroscle - rosis","volume":"47","author":"Noji","year":"2001","journal-title":"Clin Chem Lab Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1182\/blood.V74.4.1396.1396","article-title":"Functional characteristics of receptor - bound urokinase on human monocytes : cat - alytic efficiency and susceptibility to inactivation by plas - minogen activator inhibitors","volume":"11","author":"Kirchheimer","year":"1989","journal-title":"Blood"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.ATV.0000058404.92759.32","article-title":"Differential effects of doxycycline , a broad - spectrum matrix metal - loproteinase inhibitor , on angiotensin II - induced athero - sclerosis and abdominal aortic aneurysms","volume":"64","author":"Manning","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref211","first-page":"3","article-title":"et al Increased expression of membrane type - matrix metalloproteinase in human atherosclerotic plaque : role of activated macrophages and inflammatory cytokines","volume":"28","author":"Uzui","year":"2002","journal-title":"Circulation"},{"key":"ref121","first-page":"121","article-title":"Increased expression of - kd type IV collagenase ( MMP - in human aortic atherosclerotic lesions","volume":"19","author":"Li","year":"1996","journal-title":"Am J Pathol"},{"key":"ref521","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1161\/01.CIR.99.24.3199","article-title":"Expression of tissue inhibitor of matrix metalloproteinases by use of an adenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular bal - loon injury","volume":"59","author":"Dollery","year":"1999","journal-title":"Circulation"},{"key":"ref651","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.CIR.99.6.736","article-title":"Influence of low HDL on progression of coronary artery disease and response to fluvastatin ther - apy","volume":"72","author":"Ballantyne","year":"1999","journal-title":"Circulation"},{"key":"ref601","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1749-6632.1999.tb07682.x","article-title":"MMP inhibition in abdominal aortic aneurysms Rationale for a prospective random - ized clinical trial","volume":"67","author":"Thompson","year":"1999","journal-title":"Ann NY Acad Sci"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1038\/sj.onc.1205291","article-title":"YE Complex roles of tissue inhibitors of metalloproteinases in cancer","volume":"16","author":"Jiang","year":"2002","journal-title":"Oncogene"},{"key":"ref551","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1046\/j.1365-2168.1999.01196.x","article-title":"Marimastat inhibits elastin degradation and matrix metalloproteinase activity in a model of aneurysm disease","volume":"62","author":"Treharne","year":"1999","journal-title":"Br J Surg"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1139\/y99-055","article-title":"Physiological roles of matrix metalloproteinases : implications for tumor growth and metastasis Matrix turnover","volume":"6","author":"Forget","year":"1999","journal-title":"Can J Physiol Pharmacol J Orthod"},{"key":"ref611","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1161\/01.STR.0000038098.04291.F6","article-title":"Prospective randomized , double - blind trial investigating effect of doxycycline on matrix metallopro - teinase expression within atherosclerotic carotid plaques","volume":"68","author":"Axisa","year":"2002","journal-title":"Stroke"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"13055","DOI":"10.1074\/jbc.271.22.13055","article-title":"Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin - promoter which results in reduced gene expression","volume":"38","author":"Ye","year":"1996","journal-title":"J Biol Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1200\/JCO.2000.18.5.1135","article-title":"Matrix metalloproteinases : biological activity and clinical applications Matrix metalloproteinases and tissue inhibitors of metalloproteinases Structure function , and biochemistry","volume":"8","author":"Nelson","year":"2000","journal-title":"J Clin Oncol Circ Res"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/cclm.2004.42.issue-2\/cclm.2004.024\/cclm.2004.024.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/CCLM.2004.024\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T07:01:31Z","timestamp":1705215691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/CCLM.2004.024\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,18]]},"references-count":66,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1515\/cclm.2004.024","relation":{},"ISSN":["1437-4331","1434-6621"],"issn-type":[{"value":"1437-4331","type":"electronic"},{"value":"1434-6621","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1,18]]}}}